RO-250447

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NameRO-250447

Drug Alias NameRO-248705Ro-25-0447

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Carbapenems antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics

Mechanisms of ActionCell wall inhibitorsTopoisomerase (DNA) II alpha inhibitors

TargetsTopoisomerase (DNA) II alpha

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesF. Hoffmann-La Roche Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesF. Hoffmann-La Roche Ltd

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A